Home/Pipeline/TRWR‑T1D

TRWR‑T1D

Type 1 Diabetes

PreclinicalActive

Key Facts

Indication

Type 1 Diabetes

Phase

Preclinical

Status

Active

Company

Taiwan Resonant Waves Research

About Taiwan Resonant Waves Research

TRWR creates wearable bioelectronic devices that use electrical stimulation to treat chronic diseases such as diabetes and sleep disorders.

View full company profile

Therapeutic Areas

Metabolism Immunology Neurology

Other Type 1 Diabetes Drugs

Drug	Company	Phase	Status
eRapa	Biodexa Pharmaceuticals	Preclinical	Research
ImmCelz™	Creative Medical Technology Holdings	Clinical Trial	Active
Adimune (ADi-001/002)	Aditxt	Preclinical / Early Clinical	Active
MSC‑Diabetes	Advancells	Phase 1	Active
BioChaperone® Lispro (THDB0206)	Adocia	Phase 3	Active
AdoShell® Islet Cell Therapy	Adocia	Preclinical	Platform Development
Pediatric Indications (<2 years)	Tandem Diabetes	Research	Exploratory
Icovamenib (BMF-219)	Biomea Fusion	Phase 2	Completed Follow-up, Data Pending
Undisclosed Novel Strategy	CG Scientific	Pre-clinical	Early Research
Sotagliflozin	Lexicon Pharmaceuticals	Phase 3	Regulatory Path Uncertain
Stem Cell-Derived Beta Cells	BioTalentum	Pre-clinical	Active
NICHE	Continuity Biosciences	Pre-clinical	Active